A 65-year-old woman has tested positive for the new ‘Delta Plus’ variant of coronavirus here, official sources said on Thursday. The development came even as the second wave of the pandemic is waning in Madhya Pradesh and restrictions imposed to prevent the spread of the infection
Pregnant and postpartum women were more severely affected during the second wave of COVID-19 as compared to the first with symptomatic cases and the case fatality rate being significantly higher among this category this year, according to a study by ICMR. The Indian Council of Medical
Dr Reddy’s Laboratories which has soft-launched Russia’s COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. Presently it being a limited pilot phase, registration on CoWIN is not open for
The government has allowed setting up of ‘near home’ vaccination centres for elderly and differently-abled people for simplifying the process of inoculation for them. In a statement, Minister of State for Social Justice and Empowerment Rattan Lal Kataria highlighted various steps taken by the government to
With close gathering of shoppers in markets and restaurants resuming business amid phased unlock in the national capital, doctors on Tuesday cautioned that Delhi could face a “worse than second wave situation” of COVID-19 if people do not adhere to safety norms or lower their
Dismissing assumptions that children and the younger population were more affected in the second wave of Covid, the government on Tuesday said those in the 1-20 age group accounted for less than 12 per cent of the cases recorded during both the waves. Those aged 1-20
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday. There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI
The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday. This will be followed by the clinical trial of children in the age-group of 2-6
The highly transmissible Delta variant of SARS-CoV-2 has mutated further to form the Delta plus’ or AY.1′ variant but there is no immediate cause for concern in India as its incidence in the country is still low, scientists here said. The new Delta plus variant has
A single dose of COVID-19 vaccine is sufficient for an infected person as there was a greater antibody response when compared with those who have had no prior infection, according to a study released by AIG Hospitals on Monday. The city-based AIG Hospitals recently published a
